{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:04:21Z","timestamp":1794485061041,"version":"4.9.1"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.semarthrit.2023.152345","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T12:46:49Z","timestamp":1702385209000},"page":"152345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Pathogenesis, assessment, and management of bone loss in axial spondyloarthritis"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4258-1603","authenticated-orcid":false,"given":"Akihiro","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanveer","family":"Towheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2023.152345_bib0001","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrrheum.2017.56","article-title":"Pathogenesis of ankylosing spondylitis - recent advances and future directions","volume":"13","author":"Ranganathan","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0002","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/mr\/roab057","article-title":"Complexity of enthesitis and new bone formation in ankylosing spondylitis: current understanding of the immunopathology and therapeutic approaches","volume":"32","author":"Kusuda","year":"2021","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0003","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/S0140-6736(19)32534-6","article-title":"Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2\/3 trial","volume":"394","author":"van der Heijde","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0004","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0140-6736(22)01212-0","article-title":"Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"400","author":"Deodhar","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2020.101491","article-title":"Bone formation in axial spondyloarthritis: Is disease modification possible?","volume":"33","author":"Nakamura","year":"2019","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0006","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11926-021-00995-y","article-title":"Recent Updates in the Immunopathology of Type 3 Immunity-Mediated Enthesitis","volume":"23","author":"Nakamura","year":"2021","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0007","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.3390\/jcm11102830","article-title":"Prevalence and Factors of Osteoporosis and High Risk of Osteoporotic Fracture in Patients with Ankylosing Spondylitis: A Multicenter Comparative Study of Bone Mineral Density and the Fracture Risk Assessment Tool","volume":"11","author":"Kim","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0008","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/art.42120","article-title":"Vertebral Bone Mineral Density, Vertebral Strength, and Syndesmophyte Growth in Ankylosing Spondylitis: The Importance of Bridging","volume":"74","author":"Tan","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0009","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.3390\/cells9092073","article-title":"Osteoblast-Osteoclast Communication and Bone Homeostasis","volume":"9","author":"Kim","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0010","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1172\/JCI27071","article-title":"Pathogenesis of osteoporosis: concepts, conflicts, and prospects","volume":"115","author":"Raisz","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0011","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3390\/ijms23031376","article-title":"Osteoporosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover","volume":"23","author":"Cheng","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0012","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/1759720X11430858","article-title":"Aging and bone loss: new insights for the clinician","volume":"4","author":"Demontiero","year":"2012","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0013","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1084\/jem.193.3.399","article-title":"Enhancement of Osteoclastic Bone Resorption and Suppression of Osteoblastic Bone Formation in Response to Reduced Mechanical Stress Do Not Occur in the Absence of Osteopontin","volume":"193","author":"Ishijima","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0014","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2174\/1568010054022015","article-title":"Osteoblasts and osteoclasts in bone remodeling and inflammation","volume":"4","author":"Tanaka","year":"2005","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0015","first-page":"149","article-title":"The origins and roles of osteoclasts in bone development, homeostasis and repair","author":"Yahara","year":"2022","journal-title":"Development"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0016","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/421746","article-title":"Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells","volume":"2015","author":"Florencio-Silva","year":"2015","journal-title":"Biomed Res Int"},{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2023.152345_bib0017","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar2165","article-title":"Biology of RANK, RANKL, and osteoprotegerin","volume":"9","author":"Boyce","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0018","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00774-020-01191-1","article-title":"RANKL as the master regulator of osteoclast differentiation","volume":"39","author":"Takayanagi","year":"2021","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0019","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1128\/MCB.22.4.992-1000.2002","article-title":"Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6","volume":"22","author":"Mizukami","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0020","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature02444","article-title":"Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis","volume":"428","author":"Koga","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0021","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev Cell"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0022","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.20051150","article-title":"Autoamplification of NFATc1 expression determines its essential role in bone homeostasis","volume":"202","author":"Asagiri","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0023","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3390\/ijms19020360","article-title":"Mesenchymal Stem Cells: Cell Fate Decision to Osteoblast or Adipocyte and Application in Osteoporosis Treatment","volume":"19","author":"Hu","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0024","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1089\/hum.2010.115","article-title":"Bone marrow mesenchymal stem cells: historical overview and concepts","volume":"21","author":"Charbord","year":"2010","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0025","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1590\/S1807-59322011000300022","article-title":"Periosteum as a source of mesenchymal stem cells: the effects of TGF-\u03b23 on chondrogenesis","volume":"66","author":"de","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0026","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4161\/org.24279","article-title":"Adipose-derived stromal\/stem cells: a primer","volume":"9","author":"Gimble","year":"2013","journal-title":"Organogenesis"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0027","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.289.5484.1501","article-title":"The osteoblast: a sophisticated fibroblast under central surveillance","volume":"289","author":"Ducy","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0028","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1002\/jcb.23287","article-title":"Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation","volume":"112","author":"Lin","year":"2011","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0029","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.maturitas.2014.04.013","article-title":"Wnt signaling and osteoporosis","volume":"78","author":"Manolagas","year":"2014","journal-title":"Maturitas"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0030","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/art.40175","article-title":"Macrophage Migration Inhibitory Factor Induces Inflammation and Predicts Spinal Progression in Ankylosing Spondylitis","volume":"69","author":"Ranganathan","year":"2017","journal-title":"Arthritis and Rheumatology"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0031","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1038\/sj.onc.1207892","article-title":"DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin\/TCF pathway","volume":"23","author":"Niida","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0032","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","article-title":"Osteocyte control of bone formation via sclerostin, a novel BMP antagonist","volume":"22","author":"Winkler","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0033","doi-asserted-by":"crossref","first-page":"e25900","DOI":"10.1371\/journal.pone.0025900","article-title":"Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway","volume":"6","author":"Wijenayaka","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0034","first-page":"18421","article-title":"Increased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity","volume":"6","author":"Seror","year":"2016","journal-title":"Data from the ESPOIR Cohort Sci Rep"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0035","article-title":"Serum Sclerostin Levels in Patients with Ankylosing Spondylitis and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis","volume":"2017","author":"Shi","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0036","doi-asserted-by":"crossref","first-page":"11505","DOI":"10.1038\/ncomms11505","article-title":"A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair","volume":"7","author":"Florio","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0037","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.semarthrit.2017.12.001","article-title":"Prevalence and risk factors for osteoporosis and fractures in axial spondyloarthritis: A systematic review and meta-analysis","volume":"48","author":"Ram\u00edrez","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0038","article-title":"Osteoporosis in Rheumatoid Arthritis: Dangerous Liaisons","volume":"7","author":"Llorente","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0039","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1136\/annrheumdis-2019-215896","article-title":"Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations","volume":"79","author":"Orsolini","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0040","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biopha.2018.03.080","article-title":"TNF-\u03b1 contributes to postmenopausal osteoporosis by synergistically promoting RANKL-induced osteoclast formation","volume":"102","author":"Zha","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0041","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8659302","article-title":"Implication of IL-17 in Bone Loss and Structural Damage in Inflammatory Rheumatic Diseases","volume":"2019","author":"Le Goff","year":"2019","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0042","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s10067-022-06070-w","article-title":"The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis","volume":"41","author":"Atas","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0043","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.semarthrit.2008.10.008","article-title":"Wnt Pathway and IL-17: Novel Regulators of Joint Remodeling in Rheumatic Diseases. Looking Beyond the RANK-RANKL-OPG Axis","volume":"39","author":"Daoussis","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0044","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.amjmed.2009.01.022","article-title":"Osteoporosis in inflammatory bowel disease","volume":"122","author":"Ali","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.925503","article-title":"Impact of Chronic Inflammation in Psoriasis on Bone Metabolism","volume":"13","author":"Saalbach","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0046","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/14397595.2018.1510877","article-title":"Inflammation on spinal magnetic resonance imaging is associated with poor bone quality in patients with ankylosing spondylitis","volume":"29","author":"Jung","year":"2019","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0047","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.3389\/fimmu.2019.02925","article-title":"TNF-\u03b1 Directly Enhances Osteocyte RANKL Expression and Promotes Osteoclast Formation","volume":"10","author":"Marahleh","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0048","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.3390\/jcm10132905","article-title":"Bone Metabolism and RANKL\/OPG Ratio in Rheumatoid Arthritis Women Treated with TNF-\u03b1 Inhibitors","volume":"10","author":"Jura-P\u00f3\u0142torak","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0049","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10067-019-04771-3","article-title":"Effects of 1-year anti-TNF-\u03b1 therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis","volume":"39","author":"Guly\u00e1s","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.intimp.2018.04.019","article-title":"The serum level of Dickkopf-1 in patients with rheumatoid arthritis: A systematic review and meta-analysis","volume":"59","author":"Ma","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0051","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1007\/s00296-011-1981-0","article-title":"Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy","volume":"32","author":"Kwon","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0052","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jbspin.2015.03.019","article-title":"Presence of HLA-B27 is associated with changes of serum levels of mediators of the Wnt and hedgehog pathway","volume":"83","author":"Aschermann","year":"2016","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0053","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/art.41206","article-title":"Effect of Therapy on Radiographic Progression in Axial Spondyloarthritis: A Systematic Review and Meta-Analysis","volume":"72","author":"Karmacharya","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0054","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/art.42149","volume":"74","author":"Bruckmann","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0055","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200288","article-title":"Transmembrane TNF drives osteoproliferative joint inflammation reminiscent of human spondyloarthritis","volume":"217","author":"Kaaij","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0056","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI5703","article-title":"IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis","volume":"103","author":"Kotake","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0057","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar2936","article-title":"Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors","volume":"12","author":"Adamopoulos","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0058","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1186\/s12891-021-04930-1","article-title":"Effects of secukinumab on bone mineral density and bone turnover biomarkers in patients with ankylosing spondylitis: 2-year data from a phase 3 study, MEASURE 1","volume":"22","author":"Braun","year":"2021","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0059","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/rheumatology\/key375","article-title":"Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study","volume":"58","author":"Braun","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0060","first-page":"133","article-title":"Secukinumab produces a quick increase in WNT signalling antagonists in patients with psoriatic arthritis","volume":"37","author":"Fassio","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0061","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13075-018-1582-3","article-title":"IL-17A induces osteoblast differentiation by activating JAK2\/STAT3 in ankylosing spondylitis","volume":"20","author":"Jo","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0062","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001306","article-title":"Dual neutralisation of IL-17F and IL-17A with bimekizumab blocks inflammation-driven osteogenic differentiation of human periosteal cells","volume":"6","author":"Shah","year":"2020","journal-title":"RMD Open"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0063","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/art.40770","article-title":"Interleukin-17A Inhibition Diminishes Inflammation and New Bone Formation in Experimental Spondyloarthritis","volume":"71","author":"van Tok","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0064","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13075-016-0998-x","article-title":"IL-17A deficiency promotes periosteal bone formation in a model of inflammatory arthritis","volume":"18","author":"Shaw","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0065","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/rheumatology\/keab740","article-title":"A review of JAK-STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition","volume":"61","author":"McInnes","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0066","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1084\/jem.182.5.1461","article-title":"Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors","volume":"182","author":"Udagawa","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0067","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3389\/fendo.2018.00788","article-title":"Interleukin-6 Interweaves the Bone Marrow Microenvironment, Bone Loss, and Multiple Myeloma","volume":"9","author":"Harmer","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0068","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/580135","article-title":"TNF \u03b1 mediated IL-6 secretion is regulated by JAK\/STAT pathway but not by MEK phosphorylation and AKT phosphorylation in U266 multiple myeloma cells","volume":"2013","author":"Lee","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0069","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13287-017-0766-0","article-title":"Interleukin-6\/interleukin-6 receptor complex promotes osteogenic differentiation of bone marrow-derived mesenchymal stem cells","volume":"9","author":"Xie","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0070","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/excr.2002.5627","article-title":"gp130 Activation by Soluble Interleukin-6 Receptor\/Interleukin-6 Enhances Osteoblastic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells","volume":"280","author":"Erices","year":"2002","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0071","article-title":"IL-6 Contributes to the Defective Osteogenesis of Bone Marrow Stromal Cells from the Vertebral Body of the Glucocorticoid-Induced Osteoporotic Mouse","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0072","doi-asserted-by":"crossref","first-page":"11535","DOI":"10.1074\/jbc.M607999200","article-title":"Interleukin-6 Directly Inhibits Osteoclast Differentiation by Suppressing Receptor Activator of NF-\u03baB Signaling Pathways","volume":"283","author":"Yoshitake","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0073","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3325\/cmj.2016.57.89","article-title":"Interleukin 6\/Wnt interactions in rheumatoid arthritis: interleukin 6 inhibits Wnt signaling in synovial fibroblasts and osteoblasts","volume":"57","author":"Malysheva","year":"2016","journal-title":"Croat Med J"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0074","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/art.39183","article-title":"Brief Report: Tumor Necrosis Factor and Interleukin-6 Differentially Regulate Dkk-1 in the Inflamed Arthritic Joint","volume":"67","author":"Yeremenko","year":"2015","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/art.25053","volume":"62","author":"Garnero","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0076","doi-asserted-by":"crossref","first-page":"eaay4447","DOI":"10.1126\/scitranslmed.aay4447","article-title":"JAK inhibition increases bone mass in steady-state conditions and ameliorates pathological bone loss by stimulating osteoblast function","volume":"12","author":"Adam","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0077","doi-asserted-by":"crossref","first-page":"eabg1210","DOI":"10.1126\/scitranslmed.abg1210","article-title":"Macrophage migration inhibitory factor drives pathology in a mouse model of spondyloarthritis and is associated with human disease","volume":"13","author":"Nakamura","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0078","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11926-022-01081-7","article-title":"Deep Insight into the Role of MIF in Spondyloarthritis","volume":"24","author":"Wu","year":"2022","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0079","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bone.2009.06.028","article-title":"Macrophage migration inhibitory factor inhibits osteoclastogenesis","volume":"45","author":"Jacquin","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0080","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/jbmr.2854","article-title":"Macrophage Migration Inhibitory Factor (MIF) Supports Homing of Osteoclast Precursors to Peripheral Osteolytic Lesions","volume":"31","author":"Movila","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0081","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1038\/s41598-018-21776-1","article-title":"Increased mechanical loading through controlled swimming exercise induces bone formation and mineralization in adult zebrafish","volume":"8","author":"Suniaga","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0082","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1029475","article-title":"Regulation of bone health through physical exercise: Mechanisms and types","volume":"13","author":"Chang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0083","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41413-020-0099-y","article-title":"Molecular mechanosensors in osteocytes","volume":"8","author":"Qin","year":"2020","journal-title":"Bone Res"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0084","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s11914-017-0373-0","article-title":"Osteocyte Mechanobiology","volume":"15","author":"Uda","year":"2017","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0085","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1172\/JCI134214","article-title":"Osteocyte necrosis triggers osteoclast-mediated bone loss through macrophage-inducible C-type lectin","volume":"130","author":"Andreev","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0086","doi-asserted-by":"crossref","first-page":"e13172","DOI":"10.1111\/cpr.13172","article-title":"Substrate stiffness regulates the differentiation profile and functions of osteoclasts via cytoskeletal arrangement","volume":"55","author":"Wang","year":"2022","journal-title":"Cell Prolif"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0087","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1096\/fj.201901458R","article-title":"High shear stress amplitude in combination with prolonged stimulus duration determine induction of osteoclast formation by hematopoietic progenitor cells","volume":"34","author":"Bratengeier","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0088","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/03008207.2018.1459588","article-title":"Fluid shear stress promotes osteoblast proliferation through the NFATc1-ERK5 pathway","volume":"60","author":"Ding","year":"2019","journal-title":"Connect Tissue Res"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0089","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.3892\/mmr.2017.7720","article-title":"Fluid shear stress induces osteoblast differentiation and arrests the cell cycle at the G0 phase via the ERK1\/2 pathway","volume":"16","author":"Yu","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0090","doi-asserted-by":"crossref","first-page":"R108","DOI":"10.1186\/ar3833","article-title":"Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment","volume":"14","author":"Klingberg","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0091","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00296-022-05109-0","article-title":"The applicability of trabecular bone score for osteoporosis diagnosis in ankylosing spondylitis","volume":"42","author":"\u017buchowski","year":"2022","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0092","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.semarthrit.2020.07.009","article-title":"Trabecular bone loss contributes to radiographic spinal progression in patients with axial spondyloarthritis","volume":"50","author":"Jung","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0093","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1136\/ard.2010.147033","article-title":"Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48","volume":"70","author":"Song","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0094","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1136\/annrheumdis-2015-208011","article-title":"MRI vertebral corner inflammation followed by fat deposition is the strongest contributor to the development of new bone at the same vertebral corner: a multilevel longitudinal analysis in patients with ankylosing spondylitis","volume":"75","author":"Machado","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"10.1016\/j.semarthrit.2023.152345_bib0095","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/rheumatology\/XXVII.suppl_2.95","article-title":"Ileocolonoscopic findings in seronegative spondylarthropathies","volume":"27","author":"Mielants","year":"1988","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0096","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2165\/11638120-000000000-00000","article-title":"Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease","volume":"72","author":"Trikudanathan","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0097","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s41467-019-14148-4","article-title":"PTH induces bone loss via microbial-dependent expansion of intestinal TNF+ T cells and Th17 cells","volume":"11","author":"Yu","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0098","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.3899\/jrheum.2022-1272","article-title":"Differential Effects of Integrin Blockade on Gut and Sacroiliac Joint Inflammation","volume":"50","author":"Qaiyum","year":"2023","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0099","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.4049\/jimmunol.1601776","article-title":"Synthetic Retinoid AM80 Ameliorates Lung and Arthritic Autoimmune Responses by Inhibiting T Follicular Helper and Th17 Cell Responses","volume":"198","author":"Naskar","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0100","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/annrheumdis-2019-215349","article-title":"Integrin and transcriptomic profiles identify a distinctive synovial CD8+ T cell subpopulation in spondyloarthritis","volume":"78","author":"Qaiyum","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0101","article-title":"Peripheral vitamin D levels in ankylosing spondylitis: A systematic review and meta-analysis","volume":"9","author":"Diao","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152345_bib0102","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2174\/1573397117666210308122515","article-title":"Hypovitaminosis D in Patients with Ankylosing Spondylitis: Frequency and Consequences","volume":"17","author":"Elolemy","year":"2021","journal-title":"Curr Rheumatol Rev"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0103","doi-asserted-by":"crossref","first-page":"21641","DOI":"10.1038\/s41598-020-77806-4","article-title":"The potential role of vitamin D supplementation as a gut microbiota modifier in healthy individuals","volume":"10","author":"Singh","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0104","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13075-022-02853-3","article-title":"Distinctive gut microbiomes of ankylosing spondylitis and inflammatory bowel disease patients suggest differing roles in pathogenesis and correlate with disease activity","volume":"24","author":"Sternes","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41467-017-02490-4","article-title":"Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss","volume":"9","author":"Lucas","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0106","first-page":"2832","article-title":"Study of bone mineral density in patients with ankylosing spondylitis","volume":"7","author":"Singh","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0107","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s13075-017-1480-0","article-title":"Which measuring site in ankylosing spondylitis is best to detect bone loss and what predicts the decline: results from a 5-year prospective study","volume":"19","author":"Deminger","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0108","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00198-011-1766-z","article-title":"High frequency of vertebral fractures in early spondylarthropathies","volume":"23","author":"van der Weijden","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0109","article-title":"A Contemporary View of the Diagnosis of Osteoporosis in Patients With Axial Spondyloarthritis","volume":"7","author":"Lim","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0110","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ejr.2020.07.009","article-title":"Bone mineral density in ankylosing spondylitis: Relation to disease activity, functional capacity, spinal mobility and radiological damage","volume":"42","author":"Fakhreldin","year":"2020","journal-title":"The Egyptian Rheumatologist"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0111","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bone.2015.05.016","article-title":"Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice","volume":"78","author":"Harvey","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0112","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jbspin.2018.02.006","article-title":"Evaluation of bone quality with trabecular bone score in active spondyloarthritis","volume":"85","author":"Boussoualim","year":"2018","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0113","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.33549\/physiolres.934774","article-title":"Prediction of Vertebral Fractures by Trabecular Bone Score in Patients With Ankylosing Spondylitis","author":"Killinger","year":"2021","journal-title":"Physiol Res"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0114","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.3899\/jrheum.190749","article-title":"Longitudinal Association Between Trabecular Bone Loss and Disease Activity in Axial Spondyloarthritis: A 4-year Prospective Study","volume":"47","author":"Kang","year":"2020","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1471-2474-12-121","article-title":"Baseline new bone formation does not predict bone loss in ankylosing spondylitis as assessed by quantitative computed tomography (QCT): 10-year follow-up","volume":"12","author":"Korkosz","year":"2011","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0116","doi-asserted-by":"crossref","first-page":"R179","DOI":"10.1186\/ar4368","article-title":"Bone microarchitecture in ankylosing spondylitis and the association with bone mineral density, fractures, and syndesmophytes","volume":"15","author":"Klingberg","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0117","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1359\/jbmr.1997.12.8.1280","article-title":"Quantitative Ultrasound Techniques for the Assessment of Osteoporosis: Expert Agreement on Current Status","volume":"12","author":"Gl\u00fcer","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0118","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s10067-019-04876-9","article-title":"Calcaneal quantitative ultrasound has a role in out ruling low bone mineral density in axial spondyloarthropathy","volume":"39","author":"Fitzgerald","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0119","first-page":"599","article-title":"Risk assessment for osteoporosis by quantitative ultrasound of the heel in ankylosing spondylitis","volume":"21","author":"Jansen","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/ard-2022-223296","article-title":"ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update","volume":"82","author":"Ramiro","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0121","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/art.41042","article-title":"2019 Update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis","volume":"71","author":"Ward","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0122","first-page":"855","article-title":"Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment","volume":"35","author":"Briot","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0123","first-page":"1510","article-title":"Metabolism of indium-111-labeled murine monoclonal antibody in tumor and normal tissue of the athymic mouse","volume":"31","author":"Motta-Hennessy","year":"1990","journal-title":"J Nucl Med"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0124","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/ard.62.4.347","article-title":"Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha","volume":"62","author":"Allali","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.semarthrit.2014.05.008","article-title":"Effect of TNF-alpha inhibitor treatment on bone mineral density in patients with ankylosing spondylitis: a systematic review and meta-analysis","volume":"44","author":"Haroon","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0126","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/jbmr.3684","article-title":"Long-Term Treatment With TNF-Alpha Inhibitors Improves Bone Mineral Density But Not Vertebral Fracture Progression in Ankylosing Spondylitis","volume":"34","author":"Beek","year":"2019","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0127","doi-asserted-by":"crossref","first-page":"R124","DOI":"10.1186\/ar4581","article-title":"Incidence and predictors of morphometric vertebral fractures in patients with ankylosing spondylitis","volume":"16","author":"Kang","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0128","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/art.37762","article-title":"Interleukin-17A stimulates granulocyte-macrophage colony-stimulating factor release by murine osteoblasts in the presence of 1,25-dihydroxyvitamin D(3) and inhibits murine osteoclast development in vitro","volume":"65","author":"Balani","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0129","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11926-022-01084-4","article-title":"Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms","volume":"24","author":"Tam","year":"2022","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0130","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00198-021-05871-0","article-title":"Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis","volume":"32","author":"Hamar","year":"2021","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0131","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X221142346","article-title":"Fracture in clinical studies of tofacitinib in rheumatoid arthritis","volume":"14","author":"Hansen","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0132","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0133","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1073\/pnas.96.1.133","article-title":"Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro","volume":"96","author":"Fisher","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0134","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.beem.2008.07.001","article-title":"Bisphosphonates: how do they work?","volume":"22","author":"Papapoulos","year":"2008","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0135","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/bcp.14431","article-title":"Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis","volume":"87","author":"Arends","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0136","doi-asserted-by":"crossref","first-page":"e10738","DOI":"10.1097\/MD.0000000000010738","article-title":"A retrospective study of alendronate for the treatment of ankylosing spondylitis","volume":"97","author":"Li","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0137","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jocn.2021.08.016","article-title":"Effect of bisphosphonates on ankylosing spondylitis: A meta-analysis","volume":"92","author":"Eun","year":"2021","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0138","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13075-018-1665-1","article-title":"A five-year prospective study of spinal radiographic progression and its predictors in men and women with ankylosing spondylitis","volume":"20","author":"Deminger","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0139","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/BOR.0b013e328133f57b","article-title":"Antiinflammatory treatment with bisphosphonates in ankylosing spondylitis","volume":"19","author":"Toussirot","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0140","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/rheumatology\/ket321","article-title":"Bisphosphonates vs infliximab in ankylosing spondylitis treatment","volume":"53","author":"Viapiana","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0141","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/03009742.2015.1038300","article-title":"Effect of golimumab and pamidronate on clinical efficacy and MRI inflammation in axial spondyloarthritis: a 48-week open randomized trial","volume":"44","author":"Mok","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0142","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5152\/eurjrheum.2020.21162","article-title":"Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases","volume":"8","author":"Bruni","year":"2021","journal-title":"Eur J Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0143","first-page":"346","article-title":"Recommendations for the Management of Comorbidity in Patients With Axial Spondyloarthritis in Clinical Practice","volume":"14","author":"Gonzalez","year":"2018","journal-title":"Reumatol Clin (Engl Ed)"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0144","doi-asserted-by":"crossref","first-page":"dgaa048","DOI":"10.1210\/clinem\/dgaa048","article-title":"Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update","volume":"105","author":"Shoback","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0145","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years\u2019 experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0146","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/S0140-6736(17)31613-6","article-title":"Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial","volume":"390","author":"Langdahl","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0147","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2023.152345_bib0148","doi-asserted-by":"crossref","first-page":"e6970","DOI":"10.1097\/MD.0000000000006970","article-title":"Effects of teriparatide versus alendronate for treatment of postmenopausal osteoporosis: A meta-analysis of randomized controlled trials","volume":"96","author":"Wang","year":"2017","journal-title":"Medicine"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017223001877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017223001877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:12:19Z","timestamp":1758733939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017223001877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":148,"alternative-id":["S0049017223001877"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152345","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis, assessment, and management of bone loss in axial spondyloarthritis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152345","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152345"}}